PINK1: pumps, paraesthesia, punding and psychosis.

Suppr

超能文献

作者信息

Paviour Dominic C, Marion Marie-Helene

出版信息

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30.

DOI:10.1007/s00415-011-6327-z

PMID:22127616

Abstract

摘要

相似文献

PINK1: pumps, paraesthesia, punding and psychosis.

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30.

PINK1 and FLNA mutations association: A role for atypical parkinsonism?

Parkinsonism Relat Disord. 2016 May;26:78-80. doi: 10.1016/j.parkreldis.2016.02.023. Epub 2016 Mar 2.

Psychosis in Parkinson's disease: From the soft signs to the hard science.

J Neurol Sci. 2017 Aug 15;379:169-176. doi: 10.1016/j.jns.2017.06.011. Epub 2017 Jun 12.

Clozapine treatment of parkinsonism with psychosis.

J Am Geriatr Soc. 1993 Jun;41(6):669-71. doi: 10.1111/j.1532-5415.1993.tb06743.x.

Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients.

Mov Disord. 2006 Jun;21(6):875-9. doi: 10.1002/mds.20854.

Familial Parkinsonism with digenic parkin and PINK1 mutations.

Mov Disord. 2008 Jul 30;23(10):1461-5. doi: 10.1002/mds.22143.

PINK1 mutations and differential effects on mitochondrial function.

Exp Neurol. 2010 Jan;221(1):10-2. doi: 10.1016/j.expneurol.2009.10.018. Epub 2009 Oct 30.

Managing psychosis in Parkinson's disease without drugs.

Neurodegener Dis Manag. 2015 Aug;5(4):271-4. doi: 10.2217/nmt.15.27. Epub 2015 Aug 21.

Heterozygous PINK1 mutations: a susceptibility factor for Parkinson disease?

Mov Disord. 2006 Sep;21(9):1526-30. doi: 10.1002/mds.20977.

De novo psychosis in a new onset Parkinson disease.

Aust N Z J Psychiatry. 2014 Mar;48(3):292-3. doi: 10.1177/0004867413507611. Epub 2013 Oct 9.

引用本文的文献

Punding in Parkinson's Disease: An Update.

Mov Disord Clin Pract. 2023 Apr 23;10(7):1035-1047. doi: 10.1002/mdc3.13748. eCollection 2023 Jul.

A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies.

J Parkinsons Dis. 2022;12(6):1703-1725. doi: 10.3233/JPD-212986.

Nosology and Phenomenology of Psychosis in Movement Disorders.

Mov Disord Clin Pract. 2020 Jan 7;7(2):140-153. doi: 10.1002/mdc3.12882. eCollection 2020 Feb.

本文引用的文献

Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.

Mov Disord. 2010 Aug 15;25(11):1748-52. doi: 10.1002/mds.23342.

PINK1 function in health and disease.

EMBO Mol Med. 2009 Jun;1(3):152-65. doi: 10.1002/emmm.200900024.

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807.

Impulsive and compulsive behaviors in Parkinson's disease.

Mov Disord. 2009 Aug 15;24(11):1561-70. doi: 10.1002/mds.22505.

Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.

Mov Disord. 2009 Sep 15;24(12):1858-60. doi: 10.1002/mds.22652.

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

Neurol Sci. 2009 Feb;30(1):85-6. doi: 10.1007/s10072-009-0022-1. Epub 2009 Jan 24.

Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):532-5. doi: 10.1136/jnnp.2006.105676. Epub 2007 Jan 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

PINK1: pumps, paraesthesia, punding and psychosis.

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30.

PINK1 and FLNA mutations association: A role for atypical parkinsonism?

Parkinsonism Relat Disord. 2016 May;26:78-80. doi: 10.1016/j.parkreldis.2016.02.023. Epub 2016 Mar 2.

Psychosis in Parkinson's disease: From the soft signs to the hard science.

J Neurol Sci. 2017 Aug 15;379:169-176. doi: 10.1016/j.jns.2017.06.011. Epub 2017 Jun 12.

Clozapine treatment of parkinsonism with psychosis.

J Am Geriatr Soc. 1993 Jun;41(6):669-71. doi: 10.1111/j.1532-5415.1993.tb06743.x.

Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients.

Mov Disord. 2006 Jun;21(6):875-9. doi: 10.1002/mds.20854.

Familial Parkinsonism with digenic parkin and PINK1 mutations.

Mov Disord. 2008 Jul 30;23(10):1461-5. doi: 10.1002/mds.22143.

PINK1 mutations and differential effects on mitochondrial function.

Exp Neurol. 2010 Jan;221(1):10-2. doi: 10.1016/j.expneurol.2009.10.018. Epub 2009 Oct 30.

Managing psychosis in Parkinson's disease without drugs.

Neurodegener Dis Manag. 2015 Aug;5(4):271-4. doi: 10.2217/nmt.15.27. Epub 2015 Aug 21.

Heterozygous PINK1 mutations: a susceptibility factor for Parkinson disease?

Mov Disord. 2006 Sep;21(9):1526-30. doi: 10.1002/mds.20977.

De novo psychosis in a new onset Parkinson disease.

Aust N Z J Psychiatry. 2014 Mar;48(3):292-3. doi: 10.1177/0004867413507611. Epub 2013 Oct 9.

引用本文的文献

Punding in Parkinson's Disease: An Update.

Mov Disord Clin Pract. 2023 Apr 23;10(7):1035-1047. doi: 10.1002/mdc3.13748. eCollection 2023 Jul.

A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies.

J Parkinsons Dis. 2022;12(6):1703-1725. doi: 10.3233/JPD-212986.

Nosology and Phenomenology of Psychosis in Movement Disorders.

Mov Disord Clin Pract. 2020 Jan 7;7(2):140-153. doi: 10.1002/mdc3.12882. eCollection 2020 Feb.

本文引用的文献

Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.

Mov Disord. 2010 Aug 15;25(11):1748-52. doi: 10.1002/mds.23342.

PINK1 function in health and disease.

EMBO Mol Med. 2009 Jun;1(3):152-65. doi: 10.1002/emmm.200900024.

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807.

Impulsive and compulsive behaviors in Parkinson's disease.

Mov Disord. 2009 Aug 15;24(11):1561-70. doi: 10.1002/mds.22505.

Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.

Mov Disord. 2009 Sep 15;24(12):1858-60. doi: 10.1002/mds.22652.

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

Neurol Sci. 2009 Feb;30(1):85-6. doi: 10.1007/s10072-009-0022-1. Epub 2009 Jan 24.

Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):532-5. doi: 10.1136/jnnp.2006.105676. Epub 2007 Jan 3.